Nav: Home

Jeffrey M. Friedman, M.D., Ph.D., awarded 2016 Harrington Prize for Innovation in Medicine

March 15, 2016

CLEVELAND - The third annual Harrington Prize for Innovation in Medicine has been awarded to Jeffrey M. Friedman, MD, PhD, of The Rockefeller University, New York City, for his discovery of leptin and the leptin-mediated pathway that controls feeding behavior.

The Harrington Prize for Innovation in Medicine, established in 2014 by the Harrington Discovery Institute at University Hospitals (UH) in Cleveland, Ohio and The American Society for Clinical Investigation (ASCI), honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and potential for clinical application.

Dr. Friedman's discovery of leptin and the neural pathway that leptin mediates revealed the underlying mechanism of what drives feeding behavior in mice and humans. Of particular note, his discovery provided a foundation for deeper understanding of related pathologies, such as obesity - a major public-health problem at the time of this discovery in 1994 and persists around the world today.

"His truly remarkable work has been instrumental to understanding how our bodies regulate weight and what causes obesity," Marc Tessier-Lavigne, PhD, President of The Rockefeller University, said of Dr. Friedman. "Jeff is a leader in his field and an exemplary Rockefeller scientist whose transformative research sets a high bar that inspires colleagues, friends, and students within our community and around the world."

"Dr. Friedman's translational research serves as the foundation for what we know today about some of the biological factors contributing to obesity," said Levi A. Garraway, MD, PhD, Associate Professor, Medicine, Harvard Medical School, and current President of the ASCI. "This is precisely the type of research breakthrough that the Harrington Prize seeks to recognize for its impact on our understanding of the human body and how we care for it."

A committee composed of members of the ASCI Council and the Harrington Discovery Institute Scientific Advisory Board reviewed 30 nominations from 25 institutions and five countries before selecting Dr. Friedman as the recipient.

"We are pleased to join with the ASCI to honor Dr. Friedman and his team's contributions to medicine," said Jonathan Stamler, MD, Director of the Harrington Discovery Institute and the Robert S. and Sylvia K. Reitman Distinguished Chair in Cardiovascular Innovation at UH Case Medical Center and Case Western Reserve University School of Medicine. "The Harrington Discovery Institute is creating a network of the best and brightest physician-scientists from across the country and around the world, who are impacting the future of medicine. Together with ASCI, the Harrington Discovery Institute recognizes one of the true giants in our community. "

In addition to receiving a $20,000 honorarium, Dr. Friedman will deliver The Harrington Prize Lecture at the 2016 ASCI and Association of American Physicians Joint Meeting on April 15, and publish an essay in The Journal of Clinical Investigation.

Dr. Friedman received his MD from Albany Medical College in 1977 and his PhD from The Rockefeller University in 1984. He is the Marilyn M. Simpson Professor at The Rockfeller University and has been an Investigator of the Howard Hughes Medical Institute since 1996.

He is an elected member to the prestigious National Academy of Sciences and is recipient of numerous awards and honors including the Albert Lasker Basic Medical Research Award, the Shaw Prize for Life Sciences and Medicine, and the King Faisal International Prize in Medicine.

The first recipient of the Harrington Prize for Innovation in Medicine, in 2014, was Dr. Harry Dietz, a pediatric cardiologist and genetics researcher from Johns Hopkins University School of Medicine. The Prize recognized Dr. Dietz's contributions to the understanding of biology and treatment of aortic aneurysms and other connective tissue disorders. The 2015 Prize recipient was Douglas R. Lowy, MD, Chief, Laboratory of Cellular Oncology, and Acting Director of the National Cancer Institute, in recognition of his discoveries that led to the development of the Human Papillomavirus (HPV) vaccine to prevent cervical cancer.

The American Society for Clinical Investigation (ASCI), established in 1908, is one of the nation's oldest and most respected medical honor societies. The ASCI is dedicated to the advancement of research that extends the understanding and improves the treatment of human diseases, and its members are committed to mentoring future generations of physician-scientists.
-end-
Harrington Discovery Institute

The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio--part of The Harrington Project for Discovery & Development--aims to advance medicine and society by enabling our nation's most inventive physician-scientists to turn their discoveries into medicines that improve human health.

The Harrington Project for Discovery & Development

The Harrington Project for Discovery & Development (The Harrington Project), announced in late February 2012, is a first-of-its-kind $250 million national initiative, powered by a $50 million gift from the Harrington family. It includes the Harrington Discovery Institute and BioMotiv, a for-profit, mission-aligned development company that oversees a portfolio of early-stage programs, which are built to be licensed to pharmaceutical companies.

For more information about The Harrington Project, the Harrington Discovery Institute and The Harrington Prize for Innovation in Medicine, visit: http://www.HarringtonDiscovery.org

About The American Society for Clinical Investigation

The American Society for Clinical Investigation (ASCI), established in 1908, is one of the nation's oldest and most respected medical honor societies. The ASCI comprises nearly 3,000 physician-scientists from all medical specialties elected to the Society for their outstanding records of scholarly achievement in biomedical research. The ASCI represents active physician-scientists who are at the bedside, at the research bench, and at the blackboard. Many of its members are widely recognized leaders in academic medicine. The ASCI is dedicated to the advancement of research that extends our understanding and improves the treatment of human diseases, and members are committed to mentoring future generations of physician-scientists. The ASCI considers the nominations of several hundred physician-scientists from the United States and abroad each year and elects up to 80 new members each year for their significant research accomplishments. For more information, go to the-asci.org.

About University Hospitals

Founded in May 1866, University Hospitals serves the needs of patients through an integrated network of 18 hospitals, more than 40 outpatient health centers and primary care physician offices in 15 counties throughout Northeast Ohio. At the core of our $4 billion health system is University Hospitals Case Medical Center, ranked among America's best hospitals by U.S. News & World Report. The primary affiliate of Case Western Reserve University School of Medicine, UH Case Medical Center is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women's health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and genetics. Its main campus includes UH Rainbow Babies & Children's Hospital, ranked among the top children's hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University. UH is the second largest employer in Northeast Ohio with 26,000 employees. For more information, go to http://www.UHhospitals.org.

University Hospitals Case Medical Center

Related Leptin Articles:

The leptin activator: New study reveals brain receptor key to burning brown fat
In a new study published in Nature Communications, Michigan researchers reveal a pathway by which the hormone leptin contributes to weight loss.
Researchers find new mutation in the leptin gene
Texas Biomed Staff Scientist Raul Bastarrachea, M.D., is part of a team that discovered a new mutation in the gene that regulates the key hormone suppressing hunger called leptin.
Yale-led study reveals biology of leptin, the hunger hormone
In a new study, Yale researchers offer insight into leptin, a hormone that plays a key role in appetite, overeating, and obesity.
How celastrol sensitizes brains to leptin, curbing hunger and obesity
Celastrol's potent anti-obesity effects were widely reported in 2015. Derived from the roots of the thunder god vine, the drug curbed food intake in obese mice by nearly 80 percent, producing up to a 45 percent weight loss.
Leptin's neural circuit identified
Scientists identified a neural circuit in the hypothalamus as the primary mechanism mediating the hormone leptin's anti-obesity and anti-diabetes effects and found two mechanisms underlying leptin's inhibition of appetite.
Obese inducing brain mechanism
The research group of Professor Masaharu Noda, Associate Professor Takafumi Shintani, and a graduate student Satoru Higashi of the National Institute for Basic Biology (NIBB) demonstrated that protein tyrosine phosphatase receptor type J (PTPRJ) inhibits leptin signaling and that induction of PTPRJ in the hypothalamus is a cause of leptin resistance.
Study: Liver responds positively to leptin treatment in patients with lipodystrophy
Researchers at Michigan Medicine have found the livers of patients with a rare disease that affects metabolism have responded positively to leptin therapy.
Researchers come up with new answers concerning a weight-regulating hormone
For years, scientists have failed to locate the DNA variants that control the weight-regulating hormone, leptin.
Satiety hormone leptin plays a direct role in cardiovascular disease in obesity
While high levels of the satiety hormone leptin don't help obese individuals lose weight, they do appear to directly contribute to their cardiovascular disease, researchers report.
Body fat hormone leptin influences runner's high
The euphoric feeling that gives runners a motivational boost in the middle of their workout is in part modulated by the satiety hormone leptin, says new Cell Metabolism study.
More Leptin News and Leptin Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Space
One of the most consistent questions we get at the show is from parents who want to know which episodes are kid-friendly and which aren't. So today, we're releasing a separate feed, Radiolab for Kids. To kick it off, we're rerunning an all-time favorite episode: Space. In the 60's, space exploration was an American obsession. This hour, we chart the path from romance to increasing cynicism. We begin with Ann Druyan, widow of Carl Sagan, with a story about the Voyager expedition, true love, and a golden record that travels through space. And astrophysicist Neil de Grasse Tyson explains the Coepernican Principle, and just how insignificant we are. Support Radiolab today at Radiolab.org/donate.